VEA
CBIO

Virtus ETF Advisers’s Crescent Biopharma CBIO Stock Holding History

Virtus ETF Advisers’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-603
Closed -$138K – 467
2020
Q1 		$138K Sell
603
-88
-13% -$33.6K 0.06% 289
2019
Q4 		$366K Buy
691
+465
+206% +$252K 0.06% 281
2019
Q3 		$97K Sell
226
-12
-5% -$7.72K 0.02% 285
2019
Q2 		$284K Sell
238
-28
-11% -$33.5K 0.06% 239
2019
Q1 		$331K Sell
266
-33
-11% -$37.8K 0.7% 52
2018
Q4 		$283K Buy
299
+11
+4% +$13.2K 0.05% 131
2018
Q3 		$415K Sell
288
-206
-42% -$312K 0.05% 153
2018
Q2 		$797K Buy
494
+29
+6% +$49.9K 0.7% 30
2018
Q1 		$755K Buy
465
+255
+121% +$530K 0.66% 83
2017
Q4 		$352K Sell
210
-80
-28% -$106K 0.44% 85
2017
Q3 		$405K Buy
290
+27
+10% +$31.7K 0.05% 108
2017
Q2 		$294K Buy
+263
New +$217K 0.04% 127

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return